Mianus Capital

Mianus Capital is a specialist life-sciences investment firm focused on Seed and Pre-A opportunities in early-stage innovation globally.

We combine capital investment and operation support in a unique VC+CRO model to promote early-stage biotech innovation.

Our platform is differentiated by a strategic partnership with MERIT CRO, Inc., an "insider" in the drug development ecosystem with deep scientific and clinical expertise across our covered therapeutic areas. We apply a deep understanding of pre-clinical and clinical research to identify high-conviction opportunities early and provide technical endorsement that helps startup companies build credibility with partners and future investors.

We construct an ETF-style, diversified portfolio of biotech companies across therapeutic areas, balancing risk while maintaining exposure to breakthrough science. Mianus Accelerator, a strategic initiative launched by Mianus Capital, a U.S.-based early-stage investment platform backed by MERIT CRO, a premier global clinical endpoint service provider, leverages "China Speed" to accelerate clinical research for global biotech innovation.